Fi India 2026

Fi India 2026 brought together ingredient innovators, food and beverage manufacturers, R&D professionals, product developers and industry leaders shaping the future of food and nutrition. As the event marked its 20th edition, conversations focused on emerging ingredient trends, innovation, scientific advancement and the evolving demands of the global food and nutrition industry.

At Fi India 2026, Vedic Lifesciences was represented by Kriti Chaudhary, Associate Director – Partnerships & Strategy, who delivered an insightful session titled From Ingredient to Market: Designing Clinical Studies That Drive Commercial Success.

The session explored an important question for ingredient innovators: How can clinical research move beyond generating data to creating evidence that drives commercial value?

Kriti highlighted how thoughtful clinical strategy and fit-for-purpose study design can help companies make smarter decisions around clinical trials while avoiding costly research missteps. The discussion covered key considerations including study design, clinical endpoints, regulatory acceptance, product credibility, market entry and customer adoption.

A central message from the session was that a promising ingredient is only the starting point. To translate ingredient potential into meaningful commercial outcomes, companies need credible, relevant and strategically designed human evidence that can support both scientific substantiation and market positioning.

Our participation at Fi India 2026 reinforced Vedic Lifesciences’ commitment to helping food, nutrition and nutraceutical innovators build evidence strategies that connect clinical science with commercial success.